Intratumoral heterogeneity as a predictive biomarker in immunotherapy for advanced head and neck squamous cell carcinoma

被引:0
|
作者
Liu, Juying [1 ]
机构
[1] Jiangsu Canc Hosp, Radiat Dept, Nanjing, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18028
引用
收藏
页数:1
相关论文
共 50 条
  • [41] A systematic review of neoadjuvant and definitive immunotherapy in locally advanced head and neck squamous cell carcinoma
    Nindra, Udit
    Hurwitz, Joshua
    Forstner, Dion
    Chin, Venessa
    Gallagher, Richard
    Liu, Jia
    CANCER MEDICINE, 2023, 12 (10): : 11234 - 11247
  • [42] Potential of Nutritional Markers as Predictors After Immunotherapy in Advanced Head and Neck Squamous Cell Carcinoma
    Matsumura, Satoko
    Kaira, Kyoichi
    Kuba, Kiyomi
    Inoue, Hitoshi
    Hamada, Mei
    Yamazaki, Tomoko
    Nakahira, Mitsuhiko
    Ebihara, Yasuhiro
    ANTICANCER RESEARCH, 2024, 44 (09) : 4049 - 4056
  • [43] The promise of immunotherapy in head and neck squamous cell carcinoma: combinatorial immunotherapy approaches
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Psyrri, Amanda
    ESMO OPEN, 2016, 1 (06)
  • [44] Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma
    Rasmussen, Jacob H.
    Olin, Anders B.
    Lelkaitis, Giedrius
    Hansen, Adam E.
    Andersen, Flemming L.
    Johannesen, Helle H.
    Kjaer, Andreas
    Fischer, Barbara M.
    Specht, Lena
    Bentzen, Soren M.
    von Buchwald, Christian
    Wessel, Irene
    Vogelius, Ivan R.
    EUROPEAN JOURNAL OF RADIOLOGY, 2021, 139
  • [45] Intratumoral heterogeneity of esophageal squamous cell carcinoma
    Walter, Dirk
    JOURNAL OF THORACIC DISEASE, 2017, 9 (05) : E465 - E467
  • [46] Predictive Potential of Head and Neck Squamous Cell Carcinoma Organoids
    Hill, Sarah J.
    D'Andrea, Alan D.
    CANCER DISCOVERY, 2019, 9 (07) : 828 - 830
  • [47] The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck
    Wenig, BL
    Werner, JA
    Castro, DJ
    Sridhar, KS
    Garewal, HS
    Kehrl, W
    Pluzanska, A
    Arndt, O
    Costantino, PD
    Mills, GM
    Dunphy, FR
    Orenberg, EK
    Leavitt, RD
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002, 128 (08) : 880 - 885
  • [48] Predictive value of miR-27b as a potential biomarker for head and neck squamous cell carcinoma
    Yu, Xuebing
    Liu, Juan
    Zhang, Lijun
    Hu, Jihong
    Yuan, Xiaoqing
    Chen, Qiaoyun
    Xu, Jingwen
    Yan, Xinmin
    Heng, Weijun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (12): : 12615 - 12620
  • [49] CHEMOTHERAPY IN ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    LEHNERT, M
    JAKSE, R
    SEEWANN, HL
    ONKOLOGIE, 1984, 7 (05): : 297 - 299
  • [50] BLEOMYCIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF HEAD AND NECK
    GREY, P
    MICHAELS, L
    MEDICAL JOURNAL OF AUSTRALIA, 1972, 2 (05) : 246 - &